Royal Bank of Canada’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-94,260
Closed -$2.23M 7814
2023
Q4
$2.23M Buy
94,260
+22,811
+32% +$406K ﹤0.01% 2985
2023
Q3
$1.06M Buy
71,449
+65,361
+1,074% +$867K ﹤0.01% 3384
2023
Q2
$67K Buy
6,088
+6,062
+23,315% +$56.4K ﹤0.01% 5622
2023
Q1
$0 Sell
26
-10,553
-100% -$84.5K ﹤0.01% 7646
2022
Q4
$66K Buy
10,579
+2,998
+40% +$11.4K ﹤0.01% 5736
2022
Q3
$27K Buy
7,581
+6,331
+506% +$22.7K ﹤0.01% 6032
2022
Q2
$4K Sell
1,250
-3,979
-76% -$9.51K ﹤0.01% 6777
2022
Q1
$16K Sell
5,229
-8,482
-62% -$26.7K ﹤0.01% 6737
2021
Q4
$46K Buy
13,711
+5,105
+59% +$19.4K ﹤0.01% 6419
2021
Q3
$31K Buy
8,606
+2,456
+40% +$9.68K ﹤0.01% 6453
2021
Q2
$27K Sell
6,150
-1,128
-15% -$5K ﹤0.01% 6404
2021
Q1
$33K Buy
7,278
+5,698
+361% +$30.7K ﹤0.01% 6144
2020
Q4
$9K Buy
1,580
+309
+24% +$2.34K ﹤0.01% 6450
2020
Q3
$9K Sell
1,271
-1,042
-45% -$5.57K ﹤0.01% 5972
2020
Q2
$8K Sell
2,313
-11,659
-83% -$33.6K ﹤0.01% 5925
2020
Q1
$20K Buy
+13,972
New +$23.5K ﹤0.01% 5559
2019
Q4
Sell
-131
Closed -$1K 7215
2019
Q3
$1K Sell
131
-21
-14% -$127 ﹤0.01% 6545
2019
Q2
$1K Sell
152
-50
-25% -$566 ﹤0.01% 6761
2019
Q1
$2K Buy
202
+108
+115% +$1.15K ﹤0.01% 6564
2018
Q4
$1K Sell
94
-1,013
-92% -$9.64K ﹤0.01% 6631
2018
Q3
$12K Buy
+1,107
New +$13.8K ﹤0.01% 5917
2018
Q2
Sell
-1,200
Closed -$16K 6848
2018
Q1
$16K Buy
+1,200
New +$14.9K ﹤0.01% 5544
2017
Q4
Sell
-5
Closed 6994
2017
Q3
$0 Buy
+5
New +$34 ﹤0.01% 7063

Other funds holding CBAY